Aly M Abdelrahman

5PUBLICATIONS
4CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2025
Effect of Riociguat on Adenine-Induced Chronic Kidney Disease in Rats.

Aly M Abdelrahman, Raya Al Maskari, Haytham Ali

|Nov 16, 2023
Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital.

Amira M Helwani, Yousuf M Al Suleimani, Khalid Al Baimani

|Oct 27, 2022
The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats.

Aly M Abdelrahman, Badreldin H Ali, Haytham Ali

|Apr 27, 2019
Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats.

Aly M Abdelrahman, Yousuf Al Suleimani, Asem Shalaby

|Sep 13, 2018
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.

Aly M Abdelrahman, Yousuf Al Suleimani, Asem Shalaby

Pageof 1